期刊文献+

经尿道前列腺腔内剜除术治疗良性前列腺增生症临床分析 被引量:7

Transurethral Resection of Prostate with the Bipolar Plasma Kinetic Technique for Benign Prostate Hyperplasia
下载PDF
导出
摘要 目的:观察前列腺腔内剜除术治疗良性前列腺增生的安全性与有效性。方法:对80例良性前列腺增生(BPH)患者采用尿道前列腺腔内剜除术进行治疗,回顾性比较手术前后最大尿流率(Qmax)、膀胱剩余尿量(RUV)及国际前列腺症状评分(IPSS)差异。结果:80例患者手术顺利完成,术中未出现大出血、无闭孔神经损伤、术后尿失禁、经尿道电切综合征(TURS)等并发症;随访3~10个月,平均6.5个月,统计术后1周、1个月、3个月IPSS、Qmax、残余尿量,与术前比较,各项指标均有明显改善。结论:经尿道前列腺腔内剜除术(PKEP)治疗良性前列腺增生症具有操作简单、组织损伤小、机体恢复快等优点,是一种安全高效的方法。 Objective: To evaluate the clinical effect of the plasma kinetic enucleation of the prostate ( PKEP ) in treatment of benign prostatic hyperplasia ( BPH ) . Method: 80 patients with benign prostatic hyperplasia ( BPH ) were treated by transurethral enucleation of the prostate. The difference in maximum urinary flow rate ( Qmax ), bladder residual urine volume ( RUV ), and the International Prostate Symptom Score ( IPSS ) was retrospectively compared before and after surgery. Result: 80 patients got successful compli cations. Surgery did not appear intraoperative bleeding, obturator nerve injury, urinary incontinence after transurethral resection complications syndrome ( TURS ) . Followed up for 3 to 10 months , with an average of 6.5 months, statistics after one week, one month, three months, IPSS, Qmax, residual urine volume, numerical comparison with the preoperative indicators showed significant improvement. Conclusion: PKEP is effective in treating BPH. It can completely enucleate the hyperplastic tissue with little bleeding in operation. The treatment has the advantages of short catheter time and significant clinical improvements.
出处 《中国医学创新》 CAS 2013年第11期103-104,共2页 Medical Innovation of China
关键词 前列腺增生症 等离子 前列腺剜除术 Benign prostatic hyperplasia Transurethral enucleation of the prostate Transurethral resection of prostate
  • 相关文献

参考文献10

二级参考文献31

  • 1王强东,董振佳,罗时龙.经尿道双极气化前列腺剜除术40例报告[J].实用临床医学(江西),2005,6(5):82-83. 被引量:4
  • 2郑少波,刘春晓,徐亚文,李虎林,方平,徐啊白,陈玢屾.腔内剜除法在经尿道前列腺汽化电切术中的应用[J].中华泌尿外科杂志,2005,26(8):558-561. 被引量:212
  • 3钟玉蛟,施泉,曹林升.五分法经尿道前列腺电切术治疗高危重度前列腺增生(附102例报告)[J].中国男科学杂志,2007,21(5):38-40. 被引量:4
  • 4Wendt-Nordahl G,Bueher B, Hacker A, et al. Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center[J]. J Endourol, 2007,21 (9):1081-1087.
  • 5Seckiner I, Yesilli C, Akduman B, et al. A prospective randomized study for comparing bipolar plasmakinetic resection of the prostate with standard TURP[J]. Urol Int, 2006,76 (2) : 139-143.
  • 6Holtgrewe HL,Dowd JB.Transurethral prostatectomy:practice aspects of the dominant operation in America[J].J Urol,1989,141:248.
  • 7Madersbacher S,Marberger M.Is transurethral resection of the prostate still justified[J] ?BJU Int,1999,83(3):227-237.
  • 8Rassweiler J,Teber D,Kuntz R,et al.Complications of transurethral resection of the prostate (TURP)--incidence,management,and prevention[J].Eur Urol,2006,50(5):969-979.
  • 9Gupta NP,Anand A,Mishra S.Transurethral vapor resection of prostate--an alternative treatment for benign prostatic hyperplasia 》100 g[J].J Endourol,2009,23(11):1883-1886.
  • 10Roehrborn CG,Bartsch G,Kirby R,et al.Guidelines for the diagnosis and treatment of benign prostatic hyperplasia:a comparative,international overview[J].Urology,2001,58(5):642-650.

共引文献459

同被引文献57

  • 1林牧,张云飞.经直肠超声较经腹超声诊断前列腺癌的优越性[J].中国现代药物应用,2009,3(6):18-19. 被引量:5
  • 2陈铭,王峻.崔学教教授治疗前列腺增生症经验介绍[J].新中医,2004,36(12):13-14. 被引量:10
  • 3陈剑,敖建阳,宋则周.经直肠超声诊断前列腺癌的初步分析[J].中国超声诊断杂志,2006,7(4):295-296. 被引量:10
  • 4于胜强,夏术阶.非那雄胺对良性前列腺增生症并发症的预防[J].中华老年医学杂志,2006,25(11):812-813. 被引量:6
  • 5Franck-Lissbrant I,Haggstrom S,Damber J E,et al.Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats[J].Endocrinology,1998,139(452):451-456.
  • 6Haggstrom S,Wikstrom P,Bergh A,et al.Expressionof vascularendothelial growth factor and its receptorsin the rat ventral prostate and Dunning R3327 PAPadenocarcinoma before and after castration[J].Prostate,1998,36(65):71-79.
  • 7Sordello S,Bertrand N,Plouet J.Vascular endothelial growth factor is up regulated in vitro and in vivo by androgen[J].Biochem Biophy Res Commun,1998,251(123):287-290.
  • 8Pareek G,Shevchuk M,Armenakas N A,et al.The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density:a possible mechanism for decreased prostatic bleeding in treated patients[J].J Urol,2003,169(246):20-23.
  • 9Haggstrom S,Torring N,Moller K,et al.Effects of finasteride on vascular endothelial growth factor[J].Scand J Urol Nephrol,2002,36(12):182-187.
  • 10Bailey D M,Foley S J,Wedderburn A W.Effect of Finasteride on microvessel density(MVD)in patients with recurrent hematuria related to prostatic hypertrophy[J].J Urol,1999,161(63):363.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部